Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy. Ma Y, Lv M, Yuan P, Chen X, et al. BMC Cancer 2023;23:208.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma Y, Lv M, Yuan P, Chen X, et al. Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy. BMC Cancer 2023;23:208.
PMID: 36870942